Interleukin-18 mutants, their production and use

Details for Australian Patent Application No. 2002324249 (hide)

Owner Ares Trading S.A.

Inventors Dinarello, Charles; Kim, Soo-Hyun

Agent FB Rice

Pub. Number AU-B-2002324249

PCT Number PCT/IB02/02344

PCT Pub. Number WO2002/101049

Priority 60/274,327 08.03.01 US

Filing date 8 March 2002

Wipo publication date 23 December 2002

Acceptance publication date 5 April 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C12N 15/24 (2006.01) Mutation or genetic engineering

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/274,327 08.03.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002324249

5 April 2007 Application Accepted

  Published as AU-B-2002324249

2 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002324250-HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF

2002324248-POLYMORPHS OF A 1-PYRROLE DERIVATIVE, INTERMEDIATE FOR THE PREPARATION OF ATORVASTATIN